{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:36Z","timestamp":1790946696801,"version":"4.1.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Patients with Gaucher disease (GD) have progressive bone involvement that clinically presents with debilitating bone pain, structural bone changes, bone marrow infiltration (BMI), Erlenmeyer (EM) flask deformity, and osteoporosis. Pain is referred by the majority of GD patients and continues to persist despite the type of therapy. The pain in GD is described as chronic deep penetrating pain; however, sometimes, patients experience severe acute pain. The source of bone pain is mainly debated as nociceptive pain secondary to bone pathology or neuropathic or inflammatory origins. Osteocytes constitute a significant source of secreted molecules that coordinate bone remodeling. Osteocyte markers, sclerostin (SOST) and Dickkopf-1 (DKK-1), inactivate the canonical Wnt signaling pathway and lead to the inhibition of bone formation. Thus, circulated sclerostin and DKK-1 are potential biomarkers of skeletal abnormalities. This study aimed to assess the circulating levels of sclerostin and DKK-1 in patients with GD and their correlation with clinical bone pathology parameters: pain, bone mineral density (BMD), and EM deformity. Thirty-nine patients with GD were classified into cohorts based on the presence and severity of bone manifestations. The serum levels of sclerostin and DKK-1 were quantified by enzyme-linked immunosorbent assays. The highest level of sclerostin was measured in GD patients with pain, BMI, and EM deformity. The multiparameter analysis demonstrated that 95% of GD patients with pain, BMI, and EM deformity had increased levels of sclerostin. The majority of patients with elevated sclerostin also have osteopenia or osteoporosis. Moreover, circulating sclerostin level increase with age, and GD patients have elevated sclerostin levels when compared with healthy control from the same age group. Pearson\u2019s linear correlation analysis showed a positive correlation between serum DKK-1 and sclerostin in healthy controls and GD patients with normal bone mineral density. However, the balance between sclerostin and DKK-1 waned in GD patients with osteopenia or osteoporosis. In conclusion, the osteocyte marker, sclerostin, when elevated, is associated with bone pain, BMI, and EM flask deformity in GD patients. The altered sclerostin\/DKK-1 ratio correlates with the reduction of bone mineral density. These data confirm that the Wnt signaling pathway plays a role in GD-associated bone disease. Sclerostin and bone pain could be used as biomarkers to assess patients with a high risk of BMI and EM flask deformities.<\/jats:p>","DOI":"10.3389\/fendo.2022.1029130","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T06:29:40Z","timestamp":1669271380000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Margarita M.","family":"Ivanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Kasaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Goker-Alpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1615\/CritRevOncog.2013004503","article-title":"Immunological cells and functions in gaucher disease","volume":"18","author":"Pandey","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"B2","doi-asserted-by":"publisher","first-page":"192761","DOI":"10.1155\/2015\/192761","article-title":"Pathogenesis of bone alterations in gaucher disease: The role of immune system","volume":"2015","author":"Mucci","year":"2015","journal-title":"J Immunol Res"},{"key":"B3","article-title":"Grupo de estudio bone involvement gaucher d. early diagnosis of gaucher disease based on bone symptoms","volume":"80","author":"Oliveri","year":"2020","journal-title":"Medicina (B Aires)."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14156","article-title":"Presenting signs and patient co-variables in gaucher disease: outcome of the gaucher earlier diagnosis consensus (GED-c) Delphi initiative","volume":"49","author":"Mehta","year":"2019","journal-title":"Intern Med J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100\u2013105","DOI":"10.1016\/j.bcmd.2016.10.018","article-title":"Gaucheromas: When macrophages promote tumor formation and dissemination","volume":"68","author":"Ivanova","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymgme.2020.12.291","article-title":"Gaucher disease: Basic and translational science needs for more complete therapy and management","volume":"132","author":"Grabowski","year":"2021","journal-title":"Mol Genet Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jbmr.3734","article-title":"Gaucher disease in bone: From pathophysiology to practice","volume":"34","author":"Hughes","year":"2019","journal-title":"J Bone Miner Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.08.004","article-title":"Therapeutic approaches to bone pathology in gaucher disease: past, present and future","volume":"104","author":"Goker-Alpan","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13023-017-0700-7","article-title":"Chronic pain in gaucher disease: skeletal or neuropathic origin","volume":"12","author":"Devigili","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature756","article-title":"Kremen proteins are dickkopf receptors that regulate wnt\/beta-catenin signalling","volume":"417","author":"Mao","year":"2002","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0070-2153(05)73002-7","article-title":"Molecular bases of the regulation of bone remodeling by the canonical wnt signaling pathway","volume":"73","author":"Glass","year":"2006","journal-title":"Curr Top Dev Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-145169","article-title":"The role of dickkopf-1 in bone development, homeostasis, and disease","volume":"113","author":"Pinzone","year":"2009","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102217","article-title":"TRAP5b and RANKL\/OPG predict bone pathology in patients with gaucher disease","volume":"10","author":"Ivanova","year":"2021","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1759720X13510479","article-title":"Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases","volume":"6","author":"Lewiecki","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1159\/000446278","article-title":"Sclerostin and bone aging: A mini-review","volume":"62","author":"Hay","year":"2016","journal-title":"Gerontology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"Modder","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvv124","article-title":"Regulation of bone metabolism by wnt signals","volume":"159","author":"Kobayashi","year":"2016","journal-title":"J Biochem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-015-1413-6","article-title":"Association of serum dkk-1 levels with beta-catenin in patients with postmenopausal osteoporosis","volume":"35","author":"Tian","year":"2015","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1901","article-title":"Sclerostin levels associated with inhibition of the wnt\/beta-catenin signaling and reduced bone turnover in type 2 diabetes mellitus","volume":"97","author":"Gaudio","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.160.6.603","article-title":"The clinical and demographic characteristics of nonneuronopathic gaucher disease in 887 children at diagnosis","volume":"160","author":"Kaplan","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000147283.40529.13","article-title":"Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and hurler-scheie syndrome (mucopolysaccharidosis type I)","volume":"17","author":"Pastores","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/00016470410004003","article-title":"Orthopedic considerations in gaucher disease since the advent of enzyme replacement therapy","volume":"75","author":"Itzchaki","year":"2004","journal-title":"Acta Orthop Scand"},{"key":"B25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.gene.2018.08.045","article-title":"Generation of osteoclasts from type 1 gaucher patients and correlation with clinical and genetic features of disease","volume":"678","author":"Reed","year":"2018","journal-title":"Gene"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13801","article-title":"Mechanisms that drive bone pain across the lifespan","volume":"85","author":"Mantyh","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2018.06.007","article-title":"Impact of sphingolipids on osteoblast and osteoclast activity in gaucher disease","volume":"124","author":"Reed","year":"2018","journal-title":"Mol Genet Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2013.04.006","article-title":"Enhanced differentiation of osteoclasts from mononuclear precursors in patients with gaucher disease","volume":"51","author":"Reed","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ams2.46","article-title":"Acute leukemia presenting as bone pain with normal white blood cell count","volume":"1","author":"Sakata","year":"2014","journal-title":"Acute Med Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11832-007-0013-9","article-title":"Acute lymphoblastic leukemia in children: correlation of musculoskeletal manifestations and immunophenotypes","volume":"1","author":"Maman","year":"2007","journal-title":"J Child Orthop"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.11138\/ccmbm\/2015.12.2.157","article-title":"Clinical manifestations and management of gaucher disease","volume":"12","author":"Linari","year":"2015","journal-title":"Clin cases Miner Bone Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32253","article-title":"The Erlenmeyer flask bone deformity in the skeletal dysplasias","author":"Faden","year":"2009","journal-title":"Am J Med Genet A."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-020-03561-2","article-title":"Improving the quantitative classification of Erlenmeyer flask deformities","volume":"50","author":"Adusumilli","year":"2021","journal-title":"Skeletal Radiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.623893","article-title":"Bone-to-Brain: A round trip in the adaptation to mechanical stimuli","volume":"12","author":"Gerosa","year":"2021","journal-title":"Front Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2808-0","article-title":"Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles","volume":"25","author":"Sapir-Koren","year":"2014","journal-title":"Osteoporos Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.10.025","article-title":"Sost downregulation and local wnt signaling are required for the osteogenic response to mechanical loading","volume":"50","author":"Tu","year":"2012","journal-title":"Bone"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145169","article-title":"Osteocyte-related cytokines regulate osteoclast formation and bone resorption","volume":"21","author":"Kitaura","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/JME-18-0176","article-title":"Novel actions of sclerostin on bone","volume":"62","author":"Holdsworth","year":"2019","journal-title":"J Mol Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1312618","article-title":"High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density","volume":"44","author":"Voskaridou","year":"2012","journal-title":"Horm Metab Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27342","article-title":"Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy","volume":"131","author":"Terpos","year":"2012","journal-title":"Int J Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.12.224","article-title":"Osteocytes, mechanosensing and wnt signaling","volume":"42","author":"Bonewald","year":"2008","journal-title":"Bone"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx442","article-title":"Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition","volume":"27","author":"Panicker","year":"2018","journal-title":"Hum Mol Genet"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu538","article-title":"Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced wnt\/beta-catenin signaling","volume":"24","author":"Zancan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2017.10.029","article-title":"Altered differentiation potential of gaucher's disease iPSC neuronal progenitors due to wnt\/beta-catenin downregulation","volume":"9","author":"Awad","year":"2017","journal-title":"Stem Cell Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64393.sa2","article-title":"Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein","volume":"10","author":"Gould","year":"2021","journal-title":"Elife"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210617","article-title":"Impaired autophagic and mitochondrial functions are partially restored by ERT in gaucher and fabry diseases","volume":"14","author":"Ivanova","year":"2019","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.934820","article-title":"Neuronopathic gaucher disease: Beyond lysosomal dysfunction","volume":"15","author":"Arevalo","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.202934","article-title":"The emerging role of autophagic-lysosomal dysfunction in gaucher disease and parkinson's disease","volume":"12","author":"Kinghorn","year":"2017","journal-title":"Neural Regener Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1750-1172-8-140","article-title":"Unfolded protein response in gaucher disease: from human to drosophila","volume":"8","author":"Maor","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bcmd.2010.10.012","article-title":"Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant","volume":"46","author":"Bendikov-Bar","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00109-021-02174-z","article-title":"Gaucher disease - more than just a rare lipid storage disease","volume":"100","author":"Roh","year":"2022","journal-title":"J Mol Med (Berl)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090305","article-title":"Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts","volume":"24","author":"Vincent","year":"2009","journal-title":"J Bone Miner Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"9716758","DOI":"10.1155\/2019\/9716758","article-title":"Effect of TNF-alpha-Induced sclerostin on osteocytes during orthodontic tooth movement","volume":"2019","author":"Ohori","year":"2019","journal-title":"J Immunol Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24487","article-title":"TNF-alpha upregulates sclerostin expression in obese mice fed a high-fat diet","volume":"229","author":"Baek","year":"2014","journal-title":"J Cell Physiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.03.080","article-title":"TNF-alpha contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation","volume":"102","author":"Zha","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031481","article-title":"Role of the interaction of tumor necrosis factor-alpha and tumor necrosis factor receptors 1 and 2 in bone-related cells","volume":"23","author":"Kitaura","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2005.03.006","article-title":"TNF-alpha levels and TNF-alpha gene polymorphism in type I gaucher disease","volume":"31","author":"Altarescu","year":"2005","journal-title":"Cytokine"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumor necrosis factor-a (TNF-a) levels in gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2012.07.071","article-title":"Induction of osteoclastogenesis in an in vitro model of gaucher disease is mediated by T cells via TNF-alpha","volume":"509","author":"Mucci","year":"2012","journal-title":"Gene"},{"key":"B61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4248\/BR201301004","article-title":"A comprehensive overview of skeletal phenotypes associated with alterations in wnt\/beta-catenin signaling in humans and mice","volume":"1","author":"Maupin","year":"2013","journal-title":"Bone Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.002918","article-title":"Structural and functional analysis of dickkopf 4 (Dkk4): New insights into dkk evolution and regulation of wnt signaling by dkk and kremen proteins","volume":"293","author":"Patel","year":"2018","journal-title":"J Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008082","article-title":"Changes in expression of wnt signaling pathway inhibitors dickkopf-1 and sclerostin before and after total joint arthroplasty","volume":"96","author":"Lu","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4104-2","article-title":"Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults","volume":"28","author":"Coulson","year":"2017","journal-title":"Osteoporos Int"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00057","article-title":"Sclerostin and its associations with bone metabolism markers and sex hormones in healthy community-dwelling elderly individuals and adolescents","volume":"8","author":"Xu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1525-6","article-title":"Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women\u2013the six-month effect of risedronate and teriparatide","volume":"23","author":"Polyzos","year":"2012","journal-title":"Osteoporos Int"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122896","article-title":"Bone matrix levels of dickkopf and sclerostin are positively correlated with bone mass and strength in postmenopausal osteoporosis","volume":"20","author":"Ueland","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.11138\/ccmbm\/2015.12.2.165","article-title":"Gaucher disease: the role of the specialist on metabolic bone diseases","volume":"12","author":"Masi","year":"2015","journal-title":"Clin cases Miner Bone Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113439","article-title":"Anti-sclerostin antibodies in osteoporosis and other bone diseases","volume":"9","author":"Fabre","year":"2020","journal-title":"J Clin Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040787","article-title":"Osteoporosis treatment with anti-sclerostin antibodies-mechanisms of action and clinical application","volume":"10","author":"Rauner","year":"2021","journal-title":"J Clin Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-018-0446-8","article-title":"New insights in understanding and treating bone fracture pain","volume":"16","author":"Mitchell","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2016.02.007","article-title":"Bone pain: current and future treatments","volume":"28","author":"Frost","year":"2016","journal-title":"Curr Opin Pharmacol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1029130\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T06:29:44Z","timestamp":1669271384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1029130\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":72,"alternative-id":["10.3389\/fendo.2022.1029130"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1029130","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"article-number":"1029130"}}